BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/08/2022

FDA Grants Hearing on Covis Pharma Group's Proposal to Withdraw Approval of MAKENA

The FDA has scheduled a hearing to discuss Covis Pharma Group's proposal to withdraw approval of MAKENA, a new drug application, following a request from the Center for Drug Evaluation and Research.

Source: Federal Register — Food and Drug AdministrationOpen original release →